Actuate Therapeutics
BiotechnologyFort Worth, Texas, United StatesPost-IPO Equity$182.3M total fundingactuatetherapeutics.com
Latest funding:$100.0M · Post-IPO Equity (November 28, 2025)
Angel investors who backed Actuate Therapeutics
8 investors in our database backed Actuate Therapeutics.
Blake Pate
Vice President, Investments
Stella Robertson
Co-Founder, Partner
John Fucci
Partner
Steven Hood
Vice President
Daniel Schwarz
Chief Operating Officer and Chief Financial Officer
Leslie Kreis
Managing Partner and Co-Founder
Aaron Fletcher
Managing Partner and Co-Founder
Travis Whitfill
Assistant Professor Adjunct
Find the right investors for your startup
Search thousands of angel investors and VCs by industry, stage, check size, and location — and see who backed companies like Actuate Therapeutics.
Search investors